scispace - formally typeset
L

Louis P. Sandjo

Researcher at Universidade Federal de Santa Catarina

Publications -  121
Citations -  2216

Louis P. Sandjo is an academic researcher from Universidade Federal de Santa Catarina. The author has contributed to research in topics: Cytotoxicity & Chemistry. The author has an hindex of 22, co-authored 109 publications receiving 1648 citations. Previous affiliations of Louis P. Sandjo include West University of Timișoara & Pukyong National University.

Papers
More filters
Journal ArticleDOI

Rosmarinic Acid--Pharmaceutical and Clinical Aspects.

TL;DR: This review compiles data from the Pubmed, Scopus, Scifinder, Web Of Science, and Science Direct databases published between 1990 and 2015, restricting the search to works with the keywords "Rosmarinic acid" in the title.
Journal ArticleDOI

Cytotoxicity and modes of action of four Cameroonian dietary spices ethno-medically used to treat cancers: Echinops giganteus, Xylopia aethiopica, Imperata cylindrica and Piper capense.

TL;DR: The studied plants are potential cytotoxic drugs that deserve more detailed exploration in the future, to develop novel anticancer drugs against sensitive and otherwise drug-resistant phenotypes.
Journal ArticleDOI

Antimicrobial activities of the methanol extract, fractions and compounds from Ficus polita Vahl. (Moraceae).

TL;DR: The obtained results highlighted the interesting antimicrobial potency of F. polita as well as that of compound 8, and provided scientific basis for the traditional use of this taxon in the treatment of microbial infections.
Journal ArticleDOI

Cytotoxicity and modes of action of three naturally occurring xanthones (8-hydroxycudraxanthone G, morusignin I and cudraxanthone I) against sensitive and multidrug-resistant cancer cell lines

TL;DR: The cytotoxicity of the studied xanthones and especially compound 3 deserve more detailed exploration in the future to develop novel anticancer drugs against sensitive and otherwise drug-resistant phenotypes.
Journal ArticleDOI

Cytotoxic flavonoids and isoflavonoids from Erythrina sigmoidea towards multi-factorial drug resistant cancer cells.

TL;DR: Compounds from Erythrina sigmoidea and mostly 6α-hydroxyphaseollidin are potential antiproliferative natural products that deserve more investigations to develop novel anticancer drugs against sensitive and otherwise drug-resistant phenotypes.